Author

Sushil K. Mishra

University of MississippiORCID 0000-0002-3080-9754Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Organism:mouse· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Aki ShimozawaiD· 1 shared Akiyoshi KakitaiD· 1 shared Chie SekiiD· 1 shared Christian DuchoiD· 1 shared Christina L. StallingsiD· 1 shared Destinee L. ManningiD· 1 shared Hironobu EndoiD· 1 shared Hiroshi ShimizuiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Aki ShimozawaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

1,2,4-Triazole-based first-in-class non-nucleoside inhibitors of bacterial enzyme MraY

Tomayo I. Berida, Tzu‐Yu Huang, Stefanie C. Weck, Marcel Lutz, Samuel R. McKee, Nathalie Kagerah, Destinee L. Manning, Mohamed E. Jahan, Sushil K. Mishra, Jennifer E. Herrmann, Rolf Müller, Robert J. Doerksen, Christina L. Stallings, Christian Ducho, Sudeshna Roy

This paper discovers first-in-class 1,2,4-triazole-based non-nucleoside inhibitors of MraY with broad-spectrum antibacterial activity against multiple bacterial species.

ACS Bio & Med Chem Au · Sep 19, 2025Peer-reviewedBiochemistry

Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases

Hironobu Endo, Maiko Ono, Yuhei Takado, Kiwamu Matsuoka, Manami Takahashi, Kenji Tagai, Yuko Kataoka, Kosei Hirata, Keisuke Takahata, Chie Seki, Naomi Kokubo, Masayuki Fujinaga, Wakana Mori, Yuji Nagai, Koki Mimura, , Makoto Higuchi

This study develops a PET ligand to visualize α-synuclein pathologies in Parkinson's and DLB patients, showing increased signals in affected brain regions.

Neuron · Jun 5, 2024Peer-reviewedNeuroscience